REGENERON PHARMACEUTICALS, INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 57.11 | 1,000 | 57,110 | 14,000 | |
| Feb 27 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 335.00 | 1,000 | 335,000 | 14,662 | 15.7 K to 14.7 K (-6.38 %) |
| Feb 27 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 57.11 | 1,000 | 57,110 | 15,662 | 14.7 K to 15.7 K (+6.82 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 90.07 | 3,893 | 350,643 | 0 | |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 90.07 | 6,334 | 570,503 | 0 | |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 52.03 | 20,000 | 1,040,600 | 18,079 | |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 346.73 | 300 | 104,019 | 63,102 | 63.4 K to 63.1 K (-0.47 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 345.02 | 100 | 34,502 | 63,402 | 63.5 K to 63.4 K (-0.16 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 344.47 | 200 | 68,894 | 63,502 | 63.7 K to 63.5 K (-0.31 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 342.19 | 500 | 171,095 | 63,702 | 64.2 K to 63.7 K (-0.78 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 341.46 | 2,100 | 717,066 | 64,202 | 66.3 K to 64.2 K (-3.17 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 340.43 | 1,200 | 408,516 | 66,302 | 67.5 K to 66.3 K (-1.78 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 339.20 | 1,300 | 440,960 | 67,502 | 68.8 K to 67.5 K (-1.89 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 338.37 | 3,934 | 1,331,148 | 68,802 | 72.7 K to 68.8 K (-5.41 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 337.40 | 1,962 | 661,979 | 72,736 | 74.7 K to 72.7 K (-2.63 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 336.89 | 275 | 92,645 | 74,698 | 75 K to 74.7 K (-0.37 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 342.63 | 1,479 | 506,750 | 74,973 | 76.5 K to 75 K (-1.93 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 342.63 | 1,023 | 350,510 | 76,452 | 77.5 K to 76.5 K (-1.32 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 90.07 | 3,893 | 350,643 | 77,475 | 73.6 K to 77.5 K (+5.29 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 342.63 | 8,747 | 2,996,985 | 73,582 | 82.3 K to 73.6 K (-10.62 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 342.63 | 3,036 | 1,040,225 | 82,329 | 85.4 K to 82.3 K (-3.56 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 52.03 | 20,000 | 1,040,600 | 85,365 | 65.4 K to 85.4 K (+30.60 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 342.63 | 2,407 | 824,710 | 65,365 | 67.8 K to 65.4 K (-3.55 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 342.63 | 1,664 | 570,136 | 67,772 | 69.4 K to 67.8 K (-2.40 %) |
| Feb 26 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 90.07 | 6,334 | 570,503 | 69,436 | 63.1 K to 69.4 K (+10.04 %) |
| Feb 25 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 338.86 | 1,000 | 338,860 | 0 | 1,000 to 0 (-100.00 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 15.80 | 5,000 | 79,000 | 0 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 15.80 | 5,000 | 79,000 | 5,000 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 15.80 | 5,000 | 79,000 | 10,000 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 338.00 | 5,000 | 1,690,000 | 112,772 | 117.8 K to 112.8 K (-4.25 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 15.80 | 5,000 | 79,000 | 117,772 | 112.8 K to 117.8 K (+4.43 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 339.00 | 5,000 | 1,695,000 | 112,772 | 117.8 K to 112.8 K (-4.25 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 15.80 | 5,000 | 79,000 | 117,772 | 112.8 K to 117.8 K (+4.43 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 340.00 | 5,000 | 1,700,000 | 112,772 | 117.8 K to 112.8 K (-4.25 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 15.80 | 5,000 | 79,000 | 117,772 | 112.8 K to 117.8 K (+4.43 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Option Exercise | M | 18.61 | 5,000 | 93,050 | 0 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 340.00 | 5,000 | 1,700,000 | 0 | 5 K to 0 (-100.00 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Buy | M | 18.61 | 5,000 | 93,050 | 5,000 | 0 to 5 K |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 79.53 | 10,424 | 829,021 | 0 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 72.60 | 4,168 | 302,597 | 0 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 65.76 | 2,976 | 195,702 | 0 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 56.61 | 3,084 | 174,585 | 0 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Option Exercise | M | 30.63 | 30,000 | 918,900 | 66,736 | |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 339.31 | 2,203 | 747,500 | 63,102 | 65.3 K to 63.1 K (-3.37 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 338.51 | 5,204 | 1,761,606 | 65,305 | 70.5 K to 65.3 K (-7.38 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 337.51 | 2,126 | 717,546 | 70,509 | 72.6 K to 70.5 K (-2.93 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 336.42 | 4,158 | 1,398,834 | 72,635 | 76.8 K to 72.6 K (-5.41 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 335.67 | 3,143 | 1,055,011 | 76,793 | 79.9 K to 76.8 K (-3.93 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 334.45 | 2,824 | 944,487 | 79,936 | 82.8 K to 79.9 K (-3.41 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 333.90 | 300 | 100,170 | 82,760 | 83.1 K to 82.8 K (-0.36 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 332.67 | 400 | 133,068 | 83,060 | 83.5 K to 83.1 K (-0.48 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 328.50 | 500 | 164,250 | 83,460 | 84 K to 83.5 K (-0.60 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Sell | S | 327.84 | 400 | 131,136 | 83,960 | 84.4 K to 84 K (-0.47 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 996 | 324,746 | 84,360 | 85.4 K to 84.4 K (-1.17 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 535 | 174,437 | 85,356 | 85.9 K to 85.4 K (-0.62 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 56.61 | 3,084 | 174,585 | 85,891 | 82.8 K to 85.9 K (+3.72 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 1,225 | 399,411 | 82,807 | 84 K to 82.8 K (-1.46 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 600 | 195,630 | 84,032 | 84.6 K to 84 K (-0.71 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 65.76 | 2,976 | 195,702 | 84,632 | 81.7 K to 84.6 K (+3.64 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 1,670 | 544,504 | 81,656 | 83.3 K to 81.7 K (-2.00 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 927 | 302,248 | 83,326 | 84.3 K to 83.3 K (-1.10 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 72.60 | 4,168 | 302,597 | 84,253 | 80.1 K to 84.3 K (+5.20 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 4,064 | 1,325,067 | 80,085 | 84.1 K to 80.1 K (-4.83 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 2,542 | 828,819 | 84,149 | 86.7 K to 84.1 K (-2.93 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 79.53 | 10,424 | 829,021 | 86,691 | 76.3 K to 86.7 K (+13.67 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 14,017 | 4,570,243 | 76,267 | 90.3 K to 76.3 K (-15.53 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Payment of Exercise | F | 326.05 | 2,818 | 918,809 | 90,284 | 93.1 K to 90.3 K (-3.03 %) |
| Feb 24 2014 | REGN | REGENERON PHARMACE ... | GOLDBERG MURRAY A | SVP Administration ... | Buy | M | 30.63 | 30,000 | 918,900 | 93,102 | 63.1 K to 93.1 K (+47.54 %) |
| Feb 21 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 326.96 | 850 | 277,916 | 1,000 | 1.9 K to 1,000 (-45.95 %) |
| Feb 21 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 327.14 | 100 | 32,714 | 1,850 | 2 K to 1.9 K (-5.13 %) |
| Feb 21 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 327.17 | 50 | 16,359 | 1,950 | 2 K to 2 K (-2.50 %) |
| Feb 21 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.25 | 3,000 | 63,750 | 1,625 | |
| Feb 21 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.25 | 3,000 | 63,750 | 3,000 | 0 to 3 K |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 30.63 | 7,500 | 229,725 | 15,000 | |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 334.24 | 300 | 100,272 | 15,600 | 15.9 K to 15.6 K (-1.89 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 333.50 | 948 | 316,158 | 15,900 | 16.8 K to 15.9 K (-5.63 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 332.41 | 1,100 | 365,651 | 16,848 | 17.9 K to 16.8 K (-6.13 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 331.16 | 200 | 66,232 | 17,948 | 18.1 K to 17.9 K (-1.10 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 330.87 | 200 | 66,174 | 18,148 | 18.3 K to 18.1 K (-1.09 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 329.34 | 200 | 65,868 | 18,348 | 18.5 K to 18.3 K (-1.08 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 328.60 | 100 | 32,860 | 18,548 | 18.6 K to 18.5 K (-0.54 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 327.56 | 300 | 98,268 | 18,648 | 18.9 K to 18.6 K (-1.58 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 325.36 | 200 | 65,072 | 18,948 | 19.1 K to 18.9 K (-1.04 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 324.81 | 100 | 32,481 | 19,148 | 19.2 K to 19.1 K (-0.52 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 323.30 | 3,142 | 1,015,809 | 19,248 | 22.4 K to 19.2 K (-14.03 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 323.30 | 710 | 229,543 | 22,390 | 23.1 K to 22.4 K (-3.07 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 30.63 | 7,500 | 229,725 | 23,100 | 15.6 K to 23.1 K (+48.08 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 9.17 | 15,000 | 137,550 | 0 | |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 324.00 | 15,000 | 4,860,000 | 112,772 | 127.8 K to 112.8 K (-11.74 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 9.17 | 15,000 | 137,550 | 127,772 | 112.8 K to 127.8 K (+13.30 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.25 | 27,795 | 590,644 | 48,750 | |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 333.79 | 2,765 | 922,929 | 20,029 | 22.8 K to 20 K (-12.13 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 332.75 | 6,603 | 2,197,148 | 22,794 | 29.4 K to 22.8 K (-22.46 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 331.66 | 3,497 | 1,159,815 | 29,397 | 32.9 K to 29.4 K (-10.63 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 323.30 | 13,104 | 4,236,523 | 32,894 | 46 K to 32.9 K (-28.49 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 323.30 | 1,826 | 590,346 | 45,998 | 47.8 K to 46 K (-3.82 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.25 | 27,795 | 590,644 | 47,824 | 20 K to 47.8 K (+138.77 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Option Exercise | M | 177.82 | 5,000 | 889,100 | 10,000 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Option Exercise | M | 57.11 | 5,000 | 285,550 | 5,000 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Option Exercise | M | 33.42 | 5,000 | 167,100 | 0 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Option Exercise | C | 0.00 | 7,000 | 0 | 85 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Gift | G | 0.00 | 7,000 | 0 | 0 | 7 K to 0 (-100.00 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Buy | C | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Sell | S | 321.22 | 2,122 | 681,629 | 0 | 2.1 K to 0 (-100.00 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Sell | S | 320.41 | 12,878 | 4,126,240 | 2,122 | 15 K to 2.1 K (-85.85 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Buy | M | 33.42 | 5,000 | 167,100 | 15,000 | 10 K to 15 K (+50.00 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Buy | M | 57.11 | 5,000 | 285,550 | 10,000 | 5 K to 10 K (+100.00 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | SHOOTER ERIC M | Director | Buy | M | 177.82 | 5,000 | 889,100 | 5,000 | 0 to 5 K |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 21.25 | 40,000 | 850,000 | 80,295 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 16.80 | 6,548 | 110,006 | 0 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 16.80 | 8,000 | 134,400 | 6,548 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 321.17 | 1,640 | 526,719 | 24,391 | 26 K to 24.4 K (-6.30 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 320.60 | 3,575 | 1,146,145 | 26,031 | 29.6 K to 26 K (-12.08 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 319.47 | 3,819 | 1,220,056 | 29,606 | 33.4 K to 29.6 K (-11.43 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 318.51 | 6,418 | 2,044,197 | 33,425 | 39.8 K to 33.4 K (-16.11 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 317.58 | 5,360 | 1,702,229 | 39,843 | 45.2 K to 39.8 K (-11.86 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 316.55 | 1,800 | 569,790 | 45,203 | 47 K to 45.2 K (-3.83 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 3,465 | 1,124,185 | 47,003 | 50.5 K to 47 K (-6.87 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 339 | 109,985 | 50,468 | 50.8 K to 50.5 K (-0.67 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 16.80 | 6,548 | 110,006 | 50,807 | 44.3 K to 50.8 K (+14.79 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 4,234 | 1,373,679 | 44,259 | 48.5 K to 44.3 K (-8.73 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 414 | 134,318 | 48,493 | 48.9 K to 48.5 K (-0.85 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 16.80 | 8,000 | 134,400 | 48,907 | 40.9 K to 48.9 K (+19.56 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 20,865 | 6,769,441 | 40,907 | 61.8 K to 40.9 K (-33.78 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 2,619 | 849,708 | 61,772 | 64.4 K to 61.8 K (-4.07 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 21.25 | 40,000 | 850,000 | 64,391 | 24.4 K to 64.4 K (+163.99 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 320.62 | 1,000 | 320,620 | 2,000 | 3 K to 2 K (-33.33 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 314.31 | 5,720 | 1,797,853 | 5,720 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 9.49 | 189,463 | 1,798,004 | 0 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 328.50 | 1,000 | 328,500 | 1,068,343 | 1.1 M to 1.1 M (-0.09 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 327.88 | 600 | 196,728 | 1,069,343 | 1.1 M to 1.1 M (-0.06 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 326.36 | 2,100 | 685,356 | 1,069,943 | 1.1 M to 1.1 M (-0.20 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 325.44 | 1,932 | 628,750 | 1,072,043 | 1.1 M to 1.1 M (-0.18 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 324.61 | 1,700 | 551,837 | 1,073,975 | 1.1 M to 1.1 M (-0.16 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 323.42 | 1,490 | 481,896 | 1,075,675 | 1.1 M to 1.1 M (-0.14 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 322.34 | 3,874 | 1,248,745 | 1,077,165 | 1.1 M to 1.1 M (-0.36 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 321.48 | 8,021 | 2,578,591 | 1,081,039 | 1.1 M to 1.1 M (-0.74 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 320.48 | 17,274 | 5,535,972 | 1,089,060 | 1.1 M to 1.1 M (-1.56 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 319.44 | 30,858 | 9,857,280 | 1,106,334 | 1.1 M to 1.1 M (-2.71 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 318.52 | 15,816 | 5,037,712 | 1,137,192 | 1.2 M to 1.1 M (-1.37 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 317.82 | 4,322 | 1,373,618 | 1,153,008 | 1.2 M to 1.2 M (-0.37 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 314.31 | 94,756 | 29,782,758 | 1,157,330 | 1.3 M to 1.2 M (-7.57 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 314.31 | 5,720 | 1,797,853 | 1,252,086 | 1.3 M to 1.3 M (-0.45 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 9.49 | 189,463 | 1,798,004 | 1,257,806 | 1.1 M to 1.3 M (+17.73 %) |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Option Exercise | M | 18.61 | 5,000 | 93,050 | 5,000 | |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Sell | S | 320.00 | 5,000 | 1,600,000 | 0 | 5 K to 0 (-100.00 %) |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | GILMAN ALFRED G | Director | Buy | M | 18.61 | 5,000 | 93,050 | 5,000 | 0 to 5 K |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 5,819 | 178,236 | 2,611 | |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 325.00 | 5,819 | 1,891,175 | 0 | 5.8 K to 0 (-100.00 %) |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 5,819 | 178,236 | 5,819 | 0 to 5.8 K |
| Feb 12 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 325.10 | 11,475 | 3,730,523 | 103,275 | 114.8 K to 103.3 K (-10.00 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 289.98 | 2,700 | 782,937 | 16,749,620 | 16.7 M to 16.7 M (+0.02 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 288.01 | 3,237 | 932,295 | 16,746,920 | 16.7 M to 16.7 M (+0.02 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 287.27 | 8,016 | 2,302,719 | 16,743,683 | 16.7 M to 16.7 M (+0.05 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 286.38 | 7,528 | 2,155,837 | 16,735,667 | 16.7 M to 16.7 M (+0.05 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 284.49 | 505 | 143,668 | 16,728,139 | 16.7 M to 16.7 M (0.00 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 287.88 | 12,769 | 3,675,958 | 16,727,634 | 16.7 M to 16.7 M (+0.08 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 287.13 | 61,578 | 17,681,039 | 16,714,865 | 16.7 M to 16.7 M (+0.37 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 286.34 | 60,271 | 17,258,022 | 16,653,287 | 16.6 M to 16.7 M (+0.36 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 285.20 | 9,633 | 2,747,323 | 16,593,016 | 16.6 M to 16.6 M (+0.06 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 284.27 | 2,009 | 571,096 | 16,583,383 | 16.6 M to 16.6 M (+0.01 %) |
| Feb 10 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 282.84 | 265 | 74,952 | 16,581,374 | 16.6 M to 16.6 M (0.00 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 288.13 | 500 | 144,067 | 16,581,109 | 16.6 M to 16.6 M (0.00 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 286.78 | 5,412 | 1,552,053 | 16,580,609 | 16.6 M to 16.6 M (+0.03 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 285.92 | 16,173 | 4,624,152 | 16,575,197 | 16.6 M to 16.6 M (+0.10 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 284.97 | 33,907 | 9,662,491 | 16,559,024 | 16.5 M to 16.6 M (+0.21 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 283.91 | 45,362 | 12,878,476 | 16,525,117 | 16.5 M to 16.5 M (+0.28 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 282.85 | 24,995 | 7,069,878 | 16,479,755 | 16.5 M to 16.5 M (+0.15 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 281.89 | 18,605 | 5,244,532 | 16,454,760 | 16.4 M to 16.5 M (+0.11 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 280.96 | 5,088 | 1,429,522 | 16,436,155 | 16.4 M to 16.4 M (+0.03 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 279.74 | 2,983 | 834,466 | 16,431,067 | 16.4 M to 16.4 M (+0.02 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 278.54 | 7,115 | 1,981,784 | 16,428,084 | 16.4 M to 16.4 M (+0.04 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 277.49 | 15,530 | 4,309,446 | 16,420,969 | 16.4 M to 16.4 M (+0.09 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 276.53 | 16,974 | 4,693,890 | 16,405,439 | 16.4 M to 16.4 M (+0.10 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 275.48 | 6,775 | 1,866,375 | 16,388,465 | 16.4 M to 16.4 M (+0.04 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 274.64 | 7,559 | 2,075,975 | 16,381,690 | 16.4 M to 16.4 M (+0.05 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 287.78 | 40,831 | 11,750,178 | 16,374,131 | 16.3 M to 16.4 M (+0.25 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 287.18 | 67,342 | 19,339,329 | 16,333,300 | 16.3 M to 16.3 M (+0.41 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 286.15 | 36,795 | 10,528,720 | 16,265,958 | 16.2 M to 16.3 M (+0.23 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 285.08 | 22,534 | 6,423,930 | 16,229,163 | 16.2 M to 16.2 M (+0.14 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 284.12 | 12,946 | 3,678,190 | 16,206,629 | 16.2 M to 16.2 M (+0.08 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 283.17 | 8,574 | 2,427,936 | 16,193,683 | 16.2 M to 16.2 M (+0.05 %) |
| Feb 06 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 282.05 | 1,264 | 356,507 | 16,185,109 | 16.2 M to 16.2 M (+0.01 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 289.62 | 503 | 145,678 | 16,183,845 | 16.2 M to 16.2 M (0.00 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 288.14 | 1,200 | 345,773 | 16,183,342 | 16.2 M to 16.2 M (+0.01 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 287.12 | 6,619 | 1,900,467 | 16,182,142 | 16.2 M to 16.2 M (+0.04 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 286.00 | 24,692 | 7,061,979 | 16,175,523 | 16.2 M to 16.2 M (+0.15 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 285.05 | 39,366 | 11,221,204 | 16,150,831 | 16.1 M to 16.2 M (+0.24 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 284.11 | 37,908 | 10,770,008 | 16,111,465 | 16.1 M to 16.1 M (+0.24 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 283.17 | 19,805 | 5,608,116 | 16,073,557 | 16.1 M to 16.1 M (+0.12 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 282.12 | 19,448 | 5,486,641 | 16,053,752 | 16 M to 16.1 M (+0.12 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 281.14 | 20,023 | 5,629,266 | 16,034,304 | 16 M to 16 M (+0.13 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 280.04 | 20,947 | 5,865,887 | 16,014,281 | 16 M to 16 M (+0.13 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 279.14 | 7,547 | 2,106,701 | 15,993,334 | 16 M to 16 M (+0.05 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 289.90 | 9,771 | 2,832,587 | 15,985,787 | 16 M to 16 M (+0.06 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 288.77 | 300 | 86,630 | 15,976,016 | 16 M to 16 M (0.00 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 287.73 | 600 | 172,636 | 15,975,716 | 16 M to 16 M (0.00 %) |
| Feb 04 2014 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 286.14 | 243 | 69,531 | 15,897,116 | 15.9 M to 15.9 M (0.00 %) |